Skip to main content

Table 6 Distribution of overall extrahepatic distribution of distant lymphnodal metastases of HCC on FDG PET CT in 56 patients

From: Extrahepatic metastases of hepatocellular carcinoma on 18F FDG PET CT

Lymphnodal involvement

n(%)

Size range (cm)

FDG + ve

FDG-ve

SUVmax range (gm/ml)

Necrotic

Non-necrotic

Lower cervical

3(5.3%)

0.9 cm–1.5 cm

3 (5.3%)

0 (0%)

1.8–7.5

0(0%)

3(5.3%)

Subcarinal

3(5.3%)

1.3 cm–4.8 cm

3(5.3%)

0(0%)

2.5–16.8

0(0%)

3(5.3%)

Paratracheal

7(12.5%)

< 1.2 cm–2.5 cm

6 (10.7%)

1 (1.7 %)

2.5–8.6

1(1.7%)

7 (12.5%)*

Hilar

3(5.3%)

1.1 cm–1.7 cm

2 (3.5%)

1(1.7 %)

2.9–8

0(0%)

3(5.3%)

Interlobar

1(1.7%)

0.9 cm

1(1.7%)

0(0%)

3.3

0(0%)

1(1.7%)

Paracardiac

1(1.7%)

0.7 cm

0(0%)

1(1.7 %)

-

0(0%)

1(1.7%)

Juxtaphrenic

5(8.9%)

1.1 cm–2 cm

3(5.3%)

2(3.5 %)

2.1–3.5

0(0%)

5 (8.9%)

Mesenteric

4(7.1%)

< 1 cm–1.9 cm

1(1.7%)

3(5.3 %)

5.4

0(0%)

4 (7.1%)

Iliac

1(1.7%)

< 1 cm

1(1.7%)

0(0%)

4.2

0(0%)

1(1.7%)

Interlobar

2(3.5%)

1.1 cm–1.6 cm

2(3.5%)

0(0%)

3.3–4.9

1(1.7%)

1(1.7%)

Common iliac

3(5.3%)

1.5 cm–2 cm

3(5.3%)

0(0%)

6.6–9.5

0(0%)

3(5.3%)

  1. *Patient with necrotic nodes also had non necrotic lymph nodes